Welcome to eyeforpharma. Our aim is to make pharma companies better. To find out more, click here.

To cut straight to the action, choose a section from the menu above. Also follow us on twitter, subscribe to one of our monthly newsletters or find out about our upcoming conferences and events.

Pharma Job Cuts: Is There A Strategy behind The Trend?

Andrew Tolve, (Feb 8, 2010)

Andrew Tolve reports on what the spate of recent job cut announcements says about the state of big pharma

 

What will the sales rep of the future look like?

Lisa Roner, (Feb 2, 2010)

As the needs of pharma customers change, the skills and qualifications of sales rep will change, too. Lisa Roner takes a look ahead.

The changing role of sales reps in the Middle East

Lisa Roner, (Feb 2, 2010)

Lisa Roner reports on tips and trends for sales force effectiveness in the Middle Eastern and North African markets.

Getting to know the Middle Eastern and North African markets

Lisa Roner, (Feb 2, 2010)

Mohammad Hijazi, customer and disease understanding manager at Merck, Sharpe & Dohme in the United Arab Emirates, talks to Lisa Roner about implementing SFE strategies in the Middle Eastern and North African markets.

Communicating with local sales forces in the Middle Eastern and North African markets

Lisa Roner, (Feb 2, 2010)

Wael El Zanaty, communications director at sanofi-aventis, talks to Lisa Roner about communicating to and through the sales force in the MENA region.

Sales effectiveness: Moving from vendor to partner

Andrew Tolve, (Feb 2, 2010)

Joshua Rossman, director of customer experience, at eBay, on understanding your customers in order to sell better.

HTAs go global: What it means for market access

Peter Mansell, (Jan 28, 2010)

Richard Bergström, vice-chair of the EFPIA’s HTA working group, talks to Peter Mansell about how the pharma industry should respond to the globalization of health technology assessment bodies.

The European Medicines Agency’s new roadmap

Andrew Tolve, (Jan 28, 2010)

The EMA’s executive director Thomas Loenngren talks to Andrew Tolve about what to expect from the organization’s new regulatory priorities.

Gaining market access by providing value for money

Peter Mansell, (Jan 28, 2010)

Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report.

Cracking the Chinese pharma market

Rajesh Chhabara, (Jan 28, 2010)

Explosive growth in China’s pharmaceutical market presents a huge opportunity but be prepared for a bumpy ride, Rajesh Chhabara reports.


User login

Selling Pharmaceuticals in 2015 USA

February 9, 2010 - Philadelphia - Click here


SFE Middle East

March 1-2, 2010 - Cairo - Click here


Market Access Europe

March 2-3, 2010 - London - Click here


eMarketing Europe

March 3-4, 2010 - Berlin - Click here



Marketing Latin America

March 23-24, 2010 - Mexico City - Click here



Oncology USA

March, 2010 - Boston - days TBC


R&D Innovation Europe

March, 2010 - Boston - days TBC


Oncology Market Access Europe

April 13-14, 2010 - London - Click here


SFE Europe

April 27-29, 2010 - Barcelona - Click here



SFE USA

May 17-18, 2010 - Philadelphia - Click here



Marketing Excellence Japan

May 26-27, 2010 - Tokyo - Click here


Global Business Intelligence Summit

May, 2010 - Philadelphia - days TBC


Market Access Latin America

May, 2010 - Mexico City - days TBC


Sales Force Effectiveness & Market Excellence Brazil

May, 2010 - Sao Paulo - days TBC


Forecasting Europe

June 8-9, 2010 - Zurich, Switzerland - Click here


Managed Care USA

June, 2010 - Philadelphia - days TBC


Patient Relationship Marketing Europe 2009

June, 2010 - London - days TBC


Translational Medicine USA

June, 2010 - Boston - days TBC


Market Access USA

June, 2010 - Philadelphia - days TBC


Sales Force Effectiveness Japan

July 14-15, 2010 - Tokyo



Oncology Japan

October, 2010 - Tokyo - days TBC